Cipher Pharmaceuticals (CPHRF)

Cipher Pharmaceuticals (CPHRF) Financial Statements


Cipher Pharmaceuticals Financial Overview

Cipher Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.923; its P/E ratio is 6.99; Cipher Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 4.92M$ 6.07M$ 5.29M$ 4.89M$ 8.42M
Gross Profit$ 3.96M$ 4.99M$ 4.23M$ 3.91M$ 7.49M
EBIT$ 2.39M$ 7.15M$ 3.17M$ 2.71M$ 6.18M
EBITDA$ 2.67M$ 7.42M$ 3.51M$ 3.05M-
Net Income Common Stockholders$ 7.66M$ 7.03M$ 3.07M$ 2.63M$ 23.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.83M$ 42.09M$ 36.34M$ 33.43M$ 28.84M
Total Assets$ 86.03M$ 90.53M$ 80.61M$ 76.96M$ 73.78M
Total Debt$ 353.00K$ 353.00K$ 386.00K$ 403.00K$ 428.00K
Net Debt$ -39.47M$ -41.73M$ -35.95M$ -33.02M$ -28.41M
Total Liabilities$ 5.51M$ 12.98M$ 10.41M$ 9.82M$ 9.70M
Stockholders Equity$ 80.52M$ 77.55M$ 70.20M$ 67.14M$ 64.08M
Cash Flow-
Free Cash Flow$ 2.27M$ 5.97M$ 2.95M$ 4.67M$ 1.47M
Operating Cash Flow$ 2.42M$ 5.97M$ 2.95M$ 4.67M$ 1.47M
Investing Cash Flow$ -144.00K----
Financing Cash Flow$ -4.94M$ -27.00K$ -242.00K$ -34.00K$ -189.00K
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Cipher Pharmaceuticals Debt to Assets

Cipher Pharmaceuticals Cash Flow

Cipher Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis